Novocure seeks approval after pancreatic cancer wearable scores at Phase III
Novocure's Phase III PANOVA-3 study showed improved overall survival in pancreatic cancer patients treated with TTFields therapy alongside chemotherapy. Novocure plans to seek regulatory approval in key markets after positive results.